Clinical Trial

Diagnostic Performances of Preoperative Echo-guided Uterine Biopsy in the Management of Suspect Uterine Sarcoma Tumors (BIOPSAR)

Study acronym: BIOPSAR
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 2, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective multi-center interventional study that will be performed in an effort to assess the diagnostic accuracy performance of preoperative vaginal ultrasound-guided biopsy (VUGB) to detect the exact histology of uterine tumors and thereafter triage cases being eligible for morcellation during laparoscopic resection. Ten tertiary French centers will participate in the present study.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-01-29; most recent amendment 2025-10-01.
Status change: Not Yet Recruiting → Active, Not Recruiting 2024-11-15
Trial Details
NCT Number NCT04250766
Lead Sponsor Institut Bergonié
Collaborators: GIRCI SOHO
Conditions Fibroid Uterus, Sarcoma Uterus
Enrollment 19 participants
Start Date 2021-09-07
Primary Completion 2026-06 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-10-02